Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Radius Health
Special Reports
Fierce Biotech’s top 10 data readouts in 2022
There are a number of potential blockbuster drugs on the list, but it’s not all about revenue potential. Many are high-risk, high-reward compounds.
Phil Taylor
Dec 20, 2021 3:00am
Menarini, chased by 3 Big Pharmas, records breast cancer win
Oct 21, 2021 7:05am
Radius CEO Høiland set to step away from post—Chutes & Ladders
May 1, 2020 9:30am
Radius CEO Høiland hands reins to ex-Elan boss
Apr 29, 2020 10:30am
Radius plans to cut loose oncology assets
Nov 6, 2019 5:21am
Chutes & Ladders—Harper and Seidenberg unite at $320M VC fund
Sep 7, 2018 9:30am